Antidepressants utilization in Mainland China: Based on the National Health Insurance Database

Aust N Z J Psychiatry. 2023 May;57(5):767-769. doi: 10.1177/00048674221144421. Epub 2022 Dec 27.

Authors

Xinyan Zhang¹, Xiaowen Hu¹, Yuchun Cai¹, Christine Y Lu², Xiaoyan Nie^{1

2

3}, Luwen Shi^{1

3}

Affiliations

¹ Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China.
² Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA.
³ International Research Center for Medicinal Administration, Peking University Health Science Center, Beijing, China.

PMID: 36573448
DOI: 10.1177/00048674221144421

No abstract available

Publication types

Letter

MeSH terms

Antidepressive Agents / therapeutic use
China
Humans
National Health Programs*
Patient Acceptance of Health Care*

Substances

Antidepressive Agents